Jens Meiler
-
New drug candidates targeting blood clots developed through computer-aided drug design
Using computer-aided drug design, Heidi Hamm, Craig Lindsley, and Jens Meiler and their labs generated a novel series of biologically active compounds that can serve as a basis for anti–blood clot preventative drugs. Read MoreJun 11, 2024
-
WATCH: Computer science major helps fight infectious diseases with AI-focused Immersion Vanderbilt project
WATCH: Today’s fight against infectious diseases is being waged in the computer lab as much as the wet lab. Using artificial intelligence and machine learning, Vanderbilt researchers and students like School of Engineering undergraduate Karen Pu are expanding the power of computer modeling to identify mutating viruses—and potentially improve vaccines. Read MoreOct 17, 2023
-
Vanderbilt launches Center for Applied Artificial Intelligence in Protein Dynamics
Led by Vanderbilt University School of Medicine Basic Sciences professor Hassane Mchaourab, the Center for Applied Artificial Intelligence in Protein Dynamics will focus on the application of machine learning techniques to understand how proteins work. Read MoreApr 12, 2023
-
Study reveals need for matching targeted therapies with EGFR subtypes
A Vanderbilt study suggests that clinicians should take a deeper dive into distinguishing EGFR mutations when prescribing targeted therapies for non-small-cell lung cancers. Read MoreJul 28, 2022
-
Seven Vanderbilt faculty elected as AAAS fellows in 2021
Provost and Vice Chancellor for Academic Affairs C. Cybele Raver joins six others at Vanderbilt as 2021 fellows of the American Association for the Advancement of Science, the world’s largest general scientific society. Read MoreJan 26, 2022
-
Personalized Structural Biology aids cancer treatment decisions
Cancer specialists at Vanderbilt University Medical Center, in partnership with biochemists and structural biologists across the Vanderbilt University campus, are taking “personalized” cancer therapy to a new level. Read MoreApr 8, 2021
-
Vanderbilt researchers develop publicly available COVID-19 animal susceptibility prediction tool; suggests increased risk to horses
All-remote collaboration results in free animal susceptibility tool to help prioritize research and closer examination of at-risk species. Read MoreOct 6, 2020
-
Endowed chair holder celebration honors eight faculty members
Vanderbilt’s newest endowed chair holders were celebrated for their path-breaking scholarship and research by family members, donors, colleagues and friends during a Feb. 25 ceremony. Read MoreFeb 28, 2019
-
Poster session Friday will feature work on next-gen vaccines
The computer-aided design and engineering of antibodies and vaccine candidates that can neutralize viral scourges like influenza and Ebola will be the topic of an Aug. 17 poster session presented by the Vanderbilt Center for Structural Biology and the Vanderbilt Vaccine Center. Read MoreAug 6, 2018
-
Characterizing ‘keyhole’ is first step to fighting obesity at the cellular level
A Vanderbilt team and their international colleagues characterized for the first time a complex, little-understood cellular receptor type that, when activated, shuts off hunger. Read MoreApr 18, 2018
-
New working group to assess and prioritize opportunities for enhancing research IT resources on campus
The Research IT Special Project Working Group will advance the efforts of the Provost’s Initiative to Enhance Research and Scholarship, or PIERS. Read MoreMar 17, 2017
-
Transcription factor evolution
Vanderbilt researchers have discovered a novel model of evolution for factors that control gene expression. Read MoreAug 11, 2016
-
‘Young Scientist’ showcases high schoolers’ research at Vanderbilt
High school students performing advanced research at Vanderbilt have the opportunity to share their findings with the scientific community through a journal of their own. Read MoreJun 2, 2016
-
Potent HIV antibodies suggest new vaccine development approach
It’s been known for some time that the immune system can produce antibodies capable of “neutralizing” HIV, and stopping the AIDS-causing virus dead in its tracks. Read MoreApr 7, 2016
-
Dynamics of a drug resistance transporter
Vanderbilt investigators are exploring the shape changes in a multidrug transporter to understand the mechanisms of antibacterial resistance. Read MoreFeb 5, 2016
-
Chemist Jens Meiler receives Humboldt Foundation award
Associate Professor of Chemistry Jens Meiler has received a Friedrich Wilhelm Bessel Research Award from the Alexander von Humboldt Foundation in Bonn, Germany. Read MoreDec 15, 2015
-
Grant to Help Improve Flu Vaccines
Vanderbilt researchers have received a five-year, $9 million grant from the National Institutes of Health to design more effective flu vaccines and novel antibody therapies. Read MoreJul 31, 2015
-
‘Redesigned’ antibodies may control HIV: study
With the help of a computer program called “Rosetta,” researchers at Vanderbilt University have “redesigned” an antibody that has increased potency and can neutralize more strains of the AIDS-causing human immunodeficiency virus (HIV) than can any known natural antibody. Read MoreMay 21, 2015
-
VU lands $9 million NIH grant to design better flu vaccines
Vanderbilt University researchers have received a five-year, $9 million grant from the National Institutes of Health (NIH) to design more effective flu vaccines and novel antibody therapies. Read MoreMay 15, 2015
-
Chancellor Faculty Fellows Program to Advance Trans-institutional Scholarship
Fifteen faculty members from diverse disciplines have been selected as the first cohort of the Chancellor Faculty Fellows program. Read MoreMar 23, 2015